Evidence map›Paper›PMID 37316279›Full record

ArticleInternal medicine (Tokyo, Japan)2023

Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan.

Chihiro Katsuo, Kensuke Kubota, Katsushi Tanaka, Yusuke Kurita, Atsushi Nakajima

Erratum issuedOpen access · diamondAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Internal medicine (Tokyo, Japan), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Chihiro KatsuoDivision of Gastroenterology, Yokohama City University Graduate School of Medicine, Japan.
Kensuke KubotaDivision of Gastroenterology, Yokohama City University Graduate School of Medicine, Japan.
Katsushi TanakaDivision of Respiratory, Yokohama City University Graduate School of Medicine, Japan.
Yusuke KuritaDivision of Gastroenterology, Yokohama City University Graduate School of Medicine, Japan.
Atsushi NakajimaDivision of Gastroenterology, Yokohama City University Graduate School of Medicine, Japan.
Yokohama City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 51-year-old man who had been receiving steroid therapy for type 1 autoimmune pancreatitis (AIP) for 3 years contracted coronavirus disease 2019 (COVID-19). As he had a high-grade fever and dry cough, and because his SpO

Indexed as

Autoimmune PancreatitisCOVID-19Antibodies, Monoclonal, HumanizedAntibodies, NeutralizingDrug CombinationsFeverHumansJapanMaleMiddle AgedSARS-CoV-2Antibodies, Monoclonal, HumanizedAntibodies, Neutralizingcasirivimab and imdevimab drug combinationDrug Combinationsautoimmune pancreatitisCOVID19REGN-COV2 antibody combination therapy

Identifiers

PMID37316279
PMCPMC10332964
OpenAlexW4380568867

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.